MedTrace Logo

Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservation Technique With and Without Connective Tissue Graft in the Treatment of Periodontal Intraosseous Defects.

NCT07737834 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-30

No results posted yet for this study

Summary

This study is to assess the impact of implementing subepithelial connective tissue graft (SCTG) in the treatment of periodontal intrabony defects with Entire Papilla Preservation Technique (EPPT) on the clinical and radiographic results after 6 and 12 months.

Conditions

  • Intrabony Periodontal Defect

Interventions

DRUG

Enamel Matrix Derivative (EMD)- Emdogain

A biologically active material applied to the root surface after EDTA conditioning to promote periodontal regeneration.

PROCEDURE

Subepithelial Connective Tissue Graft (SCTG)

An autogenous connective tissue graft harvested from the palate and placed at the surgical site to enhance soft tissue thickness and stability.

OTHER

Bone substitute - Bio Oss Collagen

A xenogeneic bone graft material used to support bone regeneration within the intrabony defect.

PROCEDURE

Entire Papilla Preservation Technique (EPPT)

A microsurgical periodontal regenerative technique aimed at preserving the interdental papilla. The procedure includes flap elevation, defect debridement, root surface conditioning, application of regenerative materials, and primary wound closure.

OTHER

EDTA root conditioning

Application of EDTA gel to the root surface to remove the smear layer and enhance regenerative outcomes.

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Bartłomiej Górski · Depatrment of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw, Warsaw

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-09-30
Completion
2027-11-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07737834 on ClinicalTrials.gov